Ashley Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ashley Ross has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anisha Nagpal
Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
2 shared publications - Katja Maria Schmalenberger
Clinic for Psychosomatic Medicine and Psychotherapy, Ulm University Hospital, Ulm, Germany
2 shared publications - Tory Anne Eisenlohr-Moul
Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
2 shared publications - Adam Bryant Miller
Department of Psychiatry, The University of North Carolina at Chapel Hill , Chapel Hill, NC
1 shared publication Anna M. Patterson
Department of Psychiatry, University of Illinois Chicago, Chicago, Illinois; Medical Scientist Training Program, University of Illinois Chicago, Chicago, Illinois
1 shared publicationAnna Patterson
Department of Psychiatry, University of Illinois Chicago , Chicago, IL
1 shared publication
Latest Publications
- Open Access
Menstrual Cycle Exacerbation of ADHD Symptoms in Adults: Common, Person-Specific, and Not Confined to the Luteal Phase
Objective: Patients often describe menstrual-cycle worsening of attention-deficit/hyperactivity disorder (ADHD). We prospectively evaluated sample- and person-level cycle effects on ADHD symptoms and their independence from cyclical negative affect and pain. Methods: In an intensive longitudinal cohort (2019-2024), 106 naturally cycling adults meeting DSM-5 ADHD criteria on integrated assessment rated daily inattention and hyperactivity-impulsivity (Barkley Adult ADHD Rating Scale-IV), negative affect, and pain (median, 41 days) and provided daily salivary estradiol and progesterone for ovulation coding and phase-aligned cycle time (PACTS). Generalized additive models estimated sample-level and person-specific cycle curves; robust cyclicity was tested against each participant’s own time-shuffle null. Lab cognitive testing at four counterbalanced phases provided post hoc validation. Results: Sample-average cycle effects were significant yet small (<1% of daily variance), but 54% of 87 participants tested individually were robustly cyclical in ADHD symptoms (95% CI, 44%-64%; inattention 43%, hyperactivity-impulsivity 26%), more often with informant-confirmed ADHD (69% vs 36%). Among them, the cycle explained median 52% and 51% of symptom variance, a mean swing of 2.6 and 2.1 DSM-5 criteria. Most remained cyclical after adjustment for affect (68%) or pain (81%). Worsening most often peaked at and after menses rather than premenstrually; no cycle met prospective criteria for premenstrual dysphoric disorder (PMDD). Hormones did not differ by cyclicity. Conclusions: About half of these adults with ADHD showed robust cyclical symptom change, mostly not reducible to cyclical affect or pain and usually outside the premenstrual window. Future work should test its stability and whether a DSM-5 cyclical specifier is warranted.
Open AccessMenstrual Cycle Exacerbation of ADHD Symptoms in Adults: Common, Person-Specific, and Not Confined to the Luteal Phase
Objective: Patients often describe menstrual-cycle worsening of attention-deficit/hyperactivity disorder (ADHD). We prospectively evaluated sample- and person-level cycle effects on ADHD symptoms and their independence from cyclical negative affect and pain. Methods: In an intensive longitudinal cohort (2019-2024), 106 naturally cycling adults meeting DSM-5 ADHD criteria on integrated assessment rated daily inattention and hyperactivity-impulsivity (Barkley Adult ADHD Rating Scale-IV), negative affect, and pain (median, 41 days) and provided daily salivary estradiol and progesterone for ovulation coding and phase-aligned cycle time (PACTS). Generalized additive models estimated sample-level and person-specific cycle curves; robust cyclicity was tested against each participant’s own time-shuffle null. Lab cognitive testing at four counterbalanced phases provided post hoc validation. Results: Sample-average cycle effects were significant yet small (<1% of daily variance), but 54% of 87 participants tested individually were robustly cyclical in ADHD symptoms (95% CI, 44%-64%; inattention 43%, hyperactivity-impulsivity 26%), more often with informant-confirmed ADHD (69% vs 36%). Among them, the cycle explained median 52% and 51% of symptom variance, a mean swing of 2.6 and 2.1 DSM-5 criteria. Most remained cyclical after adjustment for affect (68%) or pain (81%). Worsening most often peaked at and after menses rather than premenstrually; no cycle met prospective criteria for premenstrual dysphoric disorder (PMDD). Hormones did not differ by cyclicity. Conclusions: About half of these adults with ADHD showed robust cyclical symptom change, mostly not reducible to cyclical affect or pain and usually outside the premenstrual window. Future work should test its stability and whether a DSM-5 cyclical specifier is warranted.
- 20 August 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (11)
Characterizing nonlinear heterogeneous sleep trajectories across the menstrual cycle in a transdiagnostic psychiatric population
Study Objectives: Sleep disturbance is closely linked to affective symptoms and suicidal ideation (SI). These symptoms fluctuate across the menstrual cycle; however, menstrual cycle–related sleep variability remains poorly characterized in psychiatric populations. This study examined how subjective and objective sleep fluctuate across the menstrual cycle in a psychiatric sample, considering individual differences and associations with negative affective and SI symptom trajectories. Materials and Methods: A transdiagnostic psychiatric sample recruited for recent suicidality provided intensive daily subjective sleep and symptom ratings (N = 142, M = 26.59 years, SD = 5.34) alongside wearable-derived (Oura) objective sleep measures (N = 39) across 1–3 menstrual cycles. Cycle timing was aligned to ovulation and menses using Phase-Aligned Cycle Time Scaling. Generalized additive mixed models quantified average cyclical effects and interindividual heterogeneity. Exploratory smooth mixture modeling (SMM) identified latent subgroups with shared temporal sleep trajectories which were compared to trait-level demographic and clinical characteristics as well as affective, SI, and pain cyclical symptom trajectory subgroups. Results: Most sleep outcomes showed substantial within-person cyclical variability. SMM identified distinct subgroups for Oura-derived sleep efficiency, and for subjective ratings of fatigue, insomnia, sleep quality, and hypersomnia, with patterns including perimenstrual or luteal worsening, as well as no cycle-related variability. Sleep subgroups, especially for subjective ratings, frequently significantly aligned with parallel affective, pain, and SI trajectories, suggesting temporally-coupled vulnerability. Conclusions: Sleep trajectories across the menstrual cycle are heterogeneous and meaningfully coupled with psychiatric symptom patterns. These findings support cycle-aware sleep monitoring and suggest that cyclical sleep disruption may help identify windows of heightened psychiatric risk, motivating replication and personalized intervention approaches.
- 20 August 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (11)
Characterizing nonlinear heterogeneous sleep trajectories across the menstrual cycle in a transdiagnostic psychiatric population
Study Objectives: Sleep disturbance is closely linked to affective symptoms and suicidal ideation (SI). These symptoms fluctuate across the menstrual cycle; however, menstrual cycle–related sleep variability remains poorly characterized in psychiatric populations. This study examined how subjective and objective sleep fluctuate across the menstrual cycle in a psychiatric sample, considering individual differences and associations with negative affective and SI symptom trajectories. Materials and Methods: A transdiagnostic psychiatric sample recruited for recent suicidality provided intensive daily subjective sleep and symptom ratings (N = 142, M = 26.59 years, SD = 5.34) alongside wearable-derived (Oura) objective sleep measures (N = 39) across 1–3 menstrual cycles. Cycle timing was aligned to ovulation and menses using Phase-Aligned Cycle Time Scaling. Generalized additive mixed models quantified average cyclical effects and interindividual heterogeneity. Exploratory smooth mixture modeling (SMM) identified latent subgroups with shared temporal sleep trajectories which were compared to trait-level demographic and clinical characteristics as well as affective, SI, and pain cyclical symptom trajectory subgroups. Results: Most sleep outcomes showed substantial within-person cyclical variability. SMM identified distinct subgroups for Oura-derived sleep efficiency, and for subjective ratings of fatigue, insomnia, sleep quality, and hypersomnia, with patterns including perimenstrual or luteal worsening, as well as no cycle-related variability. Sleep subgroups, especially for subjective ratings, frequently significantly aligned with parallel affective, pain, and SI trajectories, suggesting temporally-coupled vulnerability. Conclusions: Sleep trajectories across the menstrual cycle are heterogeneous and meaningfully coupled with psychiatric symptom patterns. These findings support cycle-aware sleep monitoring and suggest that cyclical sleep disruption may help identify windows of heightened psychiatric risk, motivating replication and personalized intervention approaches.
- Open Access
- 11 December 2025
- Published by Elsevier in Biological Psychiatry
- Vol. 99 (9) , 728-739
Molecular Mechanisms of Menstrual Cycle–Related Suicide Risk: A Selective Review of Promising Candidate Systems
- 11 December 2025
- Published by Elsevier in Biological Psychiatry
- Vol. 99 (9) , 728-739
Open AccessMolecular Mechanisms of Menstrual Cycle–Related Suicide Risk: A Selective Review of Promising Candidate Systems
- Open Access
- 16 October 2025
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (2) , 399-400
Hormonal contraceptive effects on the brain: considering the dual impact of endogenous and exogenous hormone flux
- 16 October 2025
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 51 (2) , 399-400
Open AccessHormonal contraceptive effects on the brain: considering the dual impact of endogenous and exogenous hormone flux